EP2314313 - Vaccine against streptococcus pneumoniae [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 02.11.2018 Database last updated on 22.08.2024 | |
Former | The patent has been granted Status updated on 24.11.2017 | ||
Former | Grant of patent is intended Status updated on 26.07.2017 | ||
Former | Examination is in progress Status updated on 27.12.2016 | Most recent event Tooltip | 12.06.2020 | Lapse of the patent in a contracting state New state(s): SE | published on 15.07.2020 [2020/29] | Applicant(s) | For all designated states GlaxoSmithKline Biologicals S.A. Rue de l'Institut, 89 1330 Rixensart / BE | [2017/52] |
Former [2011/17] | For all designated states GlaxoSmithKline Biologicals S.A. rue de l'Institut, 89 1330 Rixensart / BE | Inventor(s) | 01 /
Laferriere, Craig Antony Joseph GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 1330 Rixensart / BE | 02 /
Poolman, Jan GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 1330 Rixensart / BE | [2017/52] |
Former [2011/17] | 01 /
Laferriere, Craig Antony Joseph GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 1330 Rixensart / BE | ||
02 /
Poolman, Jan GlaxoSmithKline Biologicals s.a. Rue de l'Institut 89 1330 Rixensart / BE | Representative(s) | Johnston, Caroline Louise GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [2017/52] |
Former [2011/17] | Johnston, Caroline Louise GlaxoSmithKline Corporate Intellectual Property (CN925.1) 980 Great West Road Brentford Middlesex TW8 9GS / GB | Application number, filing date | 10178332.2 | 12.09.2001 | [2011/17] | Priority number, date | GB20000022742 | 15.09.2000 Original published format: GB 0022742 | [2011/17] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2314313 | Date: | 27.04.2011 | Language: | EN | [2011/17] | Type: | B1 Patent specification | No.: | EP2314313 | Date: | 27.12.2017 | Language: | EN | [2017/52] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 07.03.2011 | Classification | IPC: | A61K39/09, A61P31/04 | [2011/17] | CPC: |
A61K39/092 (EP,NO,US);
A61K39/09 (KR,NO);
A61K39/0208 (US);
A61K39/095 (US);
A61K39/102 (US);
A61K39/13 (US);
A61K39/292 (US);
A61K39/39 (NO);
A61P11/00 (EP);
A61P27/16 (EP);
A61P31/00 (EP);
A61P31/04 (EP);
A61P37/00 (EP);
A61K2039/55 (EP,US);
A61K2039/55572 (EP,US);
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2017/52] |
Former [2011/17] | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR | Extension states | SI | 22.09.2010 | Title | German: | Impfstoff gegen Streptococcus Pneumoniae | [2011/17] | English: | Vaccine against streptococcus pneumoniae | [2011/17] | French: | Vaccin contre streptococcus pneumoniae | [2011/17] | Examination procedure | 22.09.2010 | Examination requested [2011/17] | 13.10.2011 | Amendment by applicant (claims and/or description) | 19.12.2011 | Despatch of a communication from the examining division (Time limit: M08) | 28.08.2012 | Reply to a communication from the examining division | 03.06.2013 | Despatch of a communication from the examining division (Time limit: M09) | 09.04.2014 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 18.06.2014 | Reply to a communication from the examining division | 27.05.2015 | Despatch of a communication from the examining division (Time limit: M06) | 04.12.2015 | Reply to a communication from the examining division | 16.12.2016 | Despatch of a communication from the examining division (Time limit: M04) | 18.04.2017 | Reply to a communication from the examining division | 27.07.2017 | Communication of intention to grant the patent | 14.11.2017 | Fee for grant paid | 14.11.2017 | Fee for publishing/printing paid | 14.11.2017 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP01984626.0 / EP1317279 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010984626) is 21.05.2007 | Opposition(s) | 28.09.2018 | No opposition filed within time limit [2018/49] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 18.06.2014 | Request for further processing filed | 18.06.2014 | Full payment received (date of receipt of payment) Request granted | 23.10.2014 | Decision despatched | Fees paid | Renewal fee | 22.09.2010 | Renewal fee patent year 03 | 22.09.2010 | Renewal fee patent year 04 | 22.09.2010 | Renewal fee patent year 05 | 22.09.2010 | Renewal fee patent year 06 | 22.09.2010 | Renewal fee patent year 07 | 22.09.2010 | Renewal fee patent year 08 | 22.09.2010 | Renewal fee patent year 09 | 22.09.2010 | Renewal fee patent year 10 | 08.09.2011 | Renewal fee patent year 11 | 26.09.2012 | Renewal fee patent year 12 | 09.09.2013 | Renewal fee patent year 13 | 08.09.2014 | Renewal fee patent year 14 | 08.09.2015 | Renewal fee patent year 15 | 08.09.2016 | Renewal fee patent year 16 | 11.09.2017 | Renewal fee patent year 17 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 27.12.2017 | CY | 27.12.2017 | DK | 27.12.2017 | FI | 27.12.2017 | MC | 27.12.2017 | PT | 27.12.2017 | SE | 27.12.2017 | GR | 28.03.2018 | LU | 12.09.2018 | [2020/29] |
Former [2020/27] | AT | 27.12.2017 | |
CY | 27.12.2017 | ||
DK | 27.12.2017 | ||
FI | 27.12.2017 | ||
MC | 27.12.2017 | ||
PT | 27.12.2017 | ||
GR | 28.03.2018 | ||
LU | 12.09.2018 | ||
Former [2019/30] | AT | 27.12.2017 | |
CY | 27.12.2017 | ||
DK | 27.12.2017 | ||
FI | 27.12.2017 | ||
MC | 27.12.2017 | ||
GR | 28.03.2018 | ||
LU | 12.09.2018 | ||
Former [2019/24] | AT | 27.12.2017 | |
CY | 27.12.2017 | ||
DK | 27.12.2017 | ||
FI | 27.12.2017 | ||
MC | 27.12.2017 | ||
GR | 28.03.2018 | ||
Former [2018/51] | AT | 27.12.2017 | |
CY | 27.12.2017 | ||
DK | 27.12.2017 | ||
FI | 27.12.2017 | ||
GR | 28.03.2018 | ||
Former [2018/40] | AT | 27.12.2017 | |
CY | 27.12.2017 | ||
FI | 27.12.2017 | ||
GR | 28.03.2018 | ||
Former [2018/37] | CY | 27.12.2017 | |
FI | 27.12.2017 | ||
GR | 28.03.2018 | ||
Former [2018/26] | FI | 27.12.2017 | |
GR | 28.03.2018 | ||
Former [2018/22] | FI | 27.12.2017 | Documents cited: | Search | [XP]WO0056360 (SMITHKLINE BEECHAM BIOLOG [BE], et al) [XP] 1-14 * page 3 - page 33 * * page 39 - page 71; claims 1-23 *; | [X] - WESSELS MICHAEL R ET AL, "Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, (19980501), vol. 66, no. 5, ISSN 0019-9567, pages 2186 - 2192, XP009113849 [X] 1-14 * page 2186 - page 2191 * | [X] - OGUNNIYI A D ET AL, "IMMUNIZATION OF MICE WITH COMBINATIONS OF PNEUMOCOCCAL VIRULENCE PROTEINS ELICITS ENHANCED PROTECTION AGAINST CHALLENGE WITH STREPTOCOCCUS PNEUMONIAE", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, US, (20000501), vol. 68, no. 5, doi:10.1128/IAI.68.5.3028-3033.2000, ISSN 0019-9567, pages 3028 - 3033, XP001064855 [X] 1-14 * page 3028 - page 3032 * DOI: http://dx.doi.org/10.1128/IAI.68.5.3028-3033.2000 | [AP] - OBARO S K, "Confronting the pneumococcus: a target shift or bullet change?", VACCINE, ELSEVIER LTD, GB, (20001208), vol. 19, no. 9-10, doi:10.1016/S0264-410X(00)00262-0, ISSN 0264-410X, pages 1211 - 1217, XP004227929 [AP] 1-14 * the whole document * DOI: http://dx.doi.org/10.1016/S0264-410X(00)00262-0 | Examination | EP0534764 | WO9818930 | EP0916726 | - SOOD R K ET AL, "Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins", EXPERT OPINION ON INVESTIGATIONAL DRUGS, INFORMA HEALTHCARE, (19980301), vol. 7, no. 3, doi:10.1517/13543784.7.3.333, ISSN 1354-3784, pages 333 - 347, XP002373178 DOI: http://dx.doi.org/10.1517/13543784.7.3.333 | by applicant | US4235877 | US4372945 | EP0072513 | US4474757 | US4596556 | EP0281673 | US4790824 | GB2220211 | WO9006951 | US4940460 | US4941880 | US5064413 | EP0497524 | EP0497525 | WO9214488 | WO9303761 | WO9400153 | EP0594610 | US5312335 | WO9412641 | US5334144 | US5339163 | WO9426304 | US5383851 | WO9508348 | WO9517210 | US5466220 | US5480381 | WO9602555 | WO9605859 | US5503627 | US5520639 | US5569189 | WO9633739 | WO9634960 | WO9640928 | WO9701638 | US5599302 | WO9709994 | WO9713537 | WO9713785 | US5649912 | EP0689454 | WO9732980 | WO9737705 | WO9741151 | WO9741731 | WO9748440 | US5704911 | WO9806734 | EP0834568 | EP0837130 | WO9818930 | WO9821337 | WO9820734 | US5766608 | WO9828037 | EP0594610 | US5804193 | WO9839450 | US5843464 | WO9855606 | WO9903884 | WO9915675 | US5893397 | WO9927961 | WO9934850 | WO9951266 | WO9951188 | WO9953940 | US5993412 | WO9964067 | WO0017370 | WO0029434 | WO0037105 | WO0076540 | WO0113977 | EP1092444 | - PELTOLA ET AL., N. ENGL. J. MED., (1984), vol. 310, pages 1561 - 1566 | - ROGHMANN ET AL., J. GERONTOL., (1987), vol. 42, pages 265 - 270 | - VERGHESE; BERK, MEDICINE (BALTIMORE), (1983), vol. 62, pages 271 - 285 | - FEDSON ET AL., ARCH INTERN MED., (1994), vol. 154, pages 2531 - 2535 | - FINE ET AL., ARCH INTERN MED., (1994), vol. 154, pages 2666 - 2677 | - JAMESON; WOLF, CABIOS, (1988), vol. 4, pages 181 - 186 | - RONDA ET AL., EUR J BIOCHEM, (1987), vol. 164, pages 621 - 624 | - BERRY; PATON, INFECT IMMUN, (199612), vol. 64, no. 12, pages 5255 - 62 | - INFECT. IMMUN., (1996), vol. 64, page 3544 | - SANCHEZ-BEATO ET AL., FEMS MICROBIOL LETT, (1998), vol. 164, pages 207 - 14 | - MOSMANN, T.R.; COFFMAN, R.L., "TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties", ANNUAL REVIEW OF IMMUNOLOGY, (1989), vol. 7, doi:doi:10.1146/annurev.iy.07.040189.001045, pages 145 - 173, XP008013278 DOI: http://dx.doi.org/10.1146/annurev.iy.07.040189.001045 | - THOELEN ET AL., VACCINE, (1998), vol. 16, pages 708 - 14 | - HELMINEN ME ET AL., INFECT. IMMUN., (1993), vol. 61, pages 2003 - 2010 | - CHALOUPKA 1. ET AL., EUR. JOURNAL CLIN. MICROBIOL. INFECT. DIS., (1996), vol. 15, pages 121 - 127 | - SCHMIDT A. C. ET AL., J VIROL, (200105), pages 4594 - 4603 | - JANSON ET AL., INFECT. IMMUN., (1991), vol. 59, pages 119 - 125 | - STEINER ET AL., CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, (1997), vol. 4, page 415 | - COLLINS ET AL., NATURE, (1977), vol. 270, pages 347 - 9 | - WOODNUT; BERRY, ANTIMICROB. AG. CHEMOTHERAP., (1999), vol. 43, page 29 | - BRUYN ET AL., CLIN. INFECT. DIS., (1992), vol. 14, page 251 | - MUSHER ET AL., J. INFECT. DIS., (2000), vol. 182, page 158 | WO1999EP03038 | WO1999EP03257 | WO1999EP03824 | WO1999EP03823 | WO1999EP03822 | GB19990017977 | GB19990018038 | GB19990018208 | GB19990018302 | WO1999EP06781 | WO2000EP01468 |